Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
We started follow-up on the day after cohort entry and continued until outcome occurrence or until any of the following occurred: treatment discontinuation or starting a drug in the comparator class, death, end of continuous health plan enrollment, or end of available data
A patient with a serious non-healing musculoskeletal injury, conventional options exhausted, full informed consent, ideally inside a registered investigational protocol with structured safety monitoring
ScienceDirect , PLoS ONE , vol
AlphaMD is here to help you find a smarter path to performance
US$ 25.72
US$ 29.89
US$ 29.69
US$ 27.87
US$ 20.86
US$ 22.08
US$ 25.77
US$ 21.56
